ATE473979T1 - Verfahren zur herstellung von abacavir - Google Patents

Verfahren zur herstellung von abacavir

Info

Publication number
ATE473979T1
ATE473979T1 AT07857990T AT07857990T ATE473979T1 AT E473979 T1 ATE473979 T1 AT E473979T1 AT 07857990 T AT07857990 T AT 07857990T AT 07857990 T AT07857990 T AT 07857990T AT E473979 T1 ATE473979 T1 AT E473979T1
Authority
AT
Austria
Prior art keywords
abacavir
compound
producing
reacting
compound obtained
Prior art date
Application number
AT07857990T
Other languages
English (en)
Inventor
Ruperez Jorge Medrano
Pardo Julio Campon
Rius Laia Eloeas
Maima Ramon Berenguer
Original Assignee
Esteve Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica Sa filed Critical Esteve Quimica Sa
Application granted granted Critical
Publication of ATE473979T1 publication Critical patent/ATE473979T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/22Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT07857990T 2006-12-21 2007-12-20 Verfahren zur herstellung von abacavir ATE473979T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87134706P 2006-12-21 2006-12-21
EP06126797A EP1939196A1 (de) 2006-12-21 2006-12-21 Abacavir-Herstellungsprozess
PCT/EP2007/064371 WO2008074874A1 (en) 2006-12-21 2007-12-20 Process for the preparation of abacavir

Publications (1)

Publication Number Publication Date
ATE473979T1 true ATE473979T1 (de) 2010-07-15

Family

ID=37912446

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07857990T ATE473979T1 (de) 2006-12-21 2007-12-20 Verfahren zur herstellung von abacavir

Country Status (18)

Country Link
US (1) US8097723B2 (de)
EP (2) EP1939196A1 (de)
JP (1) JP5166438B2 (de)
KR (1) KR20090094025A (de)
CN (1) CN101563346B (de)
AT (1) ATE473979T1 (de)
AU (1) AU2007336195A1 (de)
CA (1) CA2670432A1 (de)
DE (1) DE602007007824D1 (de)
ES (1) ES2348197T3 (de)
IL (1) IL198965A (de)
MX (1) MX2009006231A (de)
NO (1) NO20092375L (de)
PL (1) PL2125814T3 (de)
RU (1) RU2447073C2 (de)
SI (1) SI2125814T1 (de)
WO (1) WO2008074874A1 (de)
ZA (1) ZA200903648B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1905772A1 (de) * 2006-09-28 2008-04-02 Esteve Quimica, S.A. Verfahren zur Herstellung von Abacavir
EP2085397A1 (de) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Kristalline Form von Abacavir
MY166057A (en) * 2012-01-03 2018-05-22 Cellceutix Corp Carbocyclic nucleosides and their pharmaceutical use and compositions
CN104788451A (zh) * 2014-01-21 2015-07-22 浙江九洲药业股份有限公司 一种阿巴卡韦的制备方法
CN109239253B (zh) * 2018-09-21 2021-07-09 江苏威奇达药业有限公司 一种阿巴卡韦的杂质的高效液相检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9402161D0 (en) * 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
GB0320738D0 (en) * 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
EP1905772A1 (de) * 2006-09-28 2008-04-02 Esteve Quimica, S.A. Verfahren zur Herstellung von Abacavir
WO2008072074A1 (en) * 2006-12-11 2008-06-19 Aurobindo Pharma Limited An improved process for the preparation of purine derivative
EP2170840A1 (de) * 2007-06-21 2010-04-07 Aurobindo Pharma Ltd Verbessertes verfahren zur herstellung eines purinderivats

Also Published As

Publication number Publication date
EP2125814A1 (de) 2009-12-02
MX2009006231A (es) 2009-06-22
CN101563346B (zh) 2011-07-27
ES2348197T3 (es) 2010-12-01
US20100041883A1 (en) 2010-02-18
JP2010513410A (ja) 2010-04-30
EP2125814B1 (de) 2010-07-14
CA2670432A1 (en) 2008-06-26
SI2125814T1 (sl) 2010-12-31
AU2007336195A1 (en) 2008-06-26
RU2447073C2 (ru) 2012-04-10
IL198965A (en) 2012-08-30
KR20090094025A (ko) 2009-09-02
JP5166438B2 (ja) 2013-03-21
PL2125814T3 (pl) 2010-12-31
IL198965A0 (en) 2010-02-17
EP1939196A1 (de) 2008-07-02
RU2009128032A (ru) 2011-01-27
DE602007007824D1 (de) 2010-08-26
US8097723B2 (en) 2012-01-17
WO2008074874A1 (en) 2008-06-26
NO20092375L (no) 2009-07-21
CN101563346A (zh) 2009-10-21
ZA200903648B (en) 2010-08-25

Similar Documents

Publication Publication Date Title
ATE475655T1 (de) Verfahren zur herstellung von (s)-4- fluormethyldihydrofuran-2-on
ATE487702T1 (de) Verfahren zum herstellen von 3-dihalomethyl- pyrazol-4-carbonsäurederivaten
NZ598012A (en) Processes for the preparation of 1,2,4-oxadiazole benzoic acids
MX2009001816A (es) Procedimiento para la produccion de acido d,l-2-hidroxi-4-alquilti o butirico.
ATE502001T1 (de) Herstellung von essigsäure
ATE473979T1 (de) Verfahren zur herstellung von abacavir
ATE552230T1 (de) Verfahren zur herstellung von derivaten aus 1-(2- halobiphenyl-4-yl)-cyclopropancarboxylsäure
WO2011077140A3 (en) Method of producing acrylic and methacrylic acid
EP1950208A4 (de) Verfahren zur herstellung von 6,6-dimethyl-3-oxabicyclo[3.1.0]hexan-2-on
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
ATE512994T1 (de) Hocheffizientes verfahren zur herstellung von polyalkylenoxidcarbonsäuren
DE502005008867D1 (de) Verfahren zur herstellung von 2,5-dimethylphenylessigsäure
ATE539071T1 (de) Verfahren zur herstellung von s-(-)-6-hydroxy-2,5,7,8-tetramethylchroman-2-ca bonsäure
DE602006003769D1 (de) Verfahren zur herstellung von 4-amino-4'-demethyl-4-desoxypodophylotoxin
ATE397593T1 (de) Verfahren zur herstellung einer vorstufe von vitamin b1
AR057345A1 (es) Proceso para preparar sales de acido cianhidrico
ATE498617T1 (de) Verfahren zur herstellung einer 3-o- alkylascorbinsäure
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
ATE517890T1 (de) Verfahren zur herstellung von reinem irbesartan
ATE519739T1 (de) Neuartiges verfahren zur herstellung von sulphonylpyrrolen als hdac-hemmer
ATE486867T1 (de) Verfahren zur herstellung von hochreinem meloxicam und meloxicam-kaliumsalz
ATE452126T1 (de) Verfahren zur herstellung von 3,4-dichlor- isothiazolcarbonsäure
DE602006008335D1 (de) Neuartiges verfahren zur herstellung von quaternärer säure und ammoniumsalzen
WO2009072139A8 (en) Process for producing 2-[1-methyl-5-(4-methylbenzoyl)- pyrrol-2- yl]acetic acid or salt thereof
ATE446960T1 (de) Verfahren zur herstellung von ziprasidone

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties